Log In
Print
BCIQ
Print
Print this Print this
 

GP2013

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionRituximab biosimilar
Molecular Target CD20
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today